Governance WuXi AppTec Co., Ltd.

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 09/07/2025			5-day change	1st Jan Change
69.70 ^CNY	-0.99%		-0.71%	+26.64%

08/07	Blackrock's long position in H shares of Wuxi Apptec decreases on July 2 - HKEX	RE
30/06	CANbridge Pharmaceuticals Inc. Announces Board and Committee Changes, Effective June 30, 2025	CI

Executive Committee: WuXi AppTec Co., Ltd.

Manager

Positions heldSince

Qing Yang

56 year

Chief Executive Officer

21/05/2020

Ellis Chu

Director of Finance/CFO

Guo Dong Tong

Chief Operating Officer

Ming Shi

50 year

Director of Finance/CFO

01/01/2022

Florence Shi

51 year

Director of Finance/CFO

01/01/2022

Yuet Fan Cheung

60 year

Corporate Secretary

25/05/2022

Yuanzhou Zhang

36 year

Corporate Secretary

06/06/2023

Frederick Hausheer

Chief Tech/Sci/R&D Officer

08/04/2019

Edward Hu

62 year

Chief Investment Officer

23/03/2016

Ge Li

57 year

Chief Executive Officer	06/06/2023
Founder	01/12/2000
President	01/12/2000

Min Zhang Chen

55 year

Chief Executive Officer

02/08/2021

Composition of the Board of Directors: WuXi AppTec Co., Ltd.

Director

CommitteesSince

Ge Li

57 year

Finance Committee	01/01/2004
Compensation Committee	01/01/2004
Nominating Committee
Nominating Committee Chair	01/02/2014

Xue Song Leng

56 year

Audit Committee	01/09/2018
Compensation Committee Chair	01/09/2018
Governance Committee Chair	01/09/2018
Nominating Committee Chair	01/09/2018
Compensation Committee	22/01/2025
HR Committee	22/01/2025
Nominating Committee	22/01/2025

Xin Zhang

48 year

Audit Committee Chair	10/04/2018
Audit Committee	31/05/2023
Nominating Committee

Wei Yu

72 year

Audit Committee	31/05/2023
Compensation Committee	09/12/2020
Nominating Committee	09/12/2020

Xiao Meng Tong

51 year

Audit Committee
Nominating Committee
Compensation Committee Chair

Shao Hua Lu-Wong

56 year

Audit Committee Chair	01/12/2024
Nominating Committee	01/12/2024

Edward Hu

62 year

Audit Committee

Zhi Ling Zhan

62 year

Nominating Committee

31/05/2023

Min Zhang Chen

55 year

Director/Board Member

06/05/2022

Harry He

59 year

Chairman

15/07/2016

Zhao Hui Zhang

55 year

Director/Board Member

01/12/2000

Min Fang Zhu

54 year

Director/Board Member

11/03/2016

Yi Bing Wu

56 year

Director/Board Member

23/03/2016

Bo Yang Wu

61 year

Director/Board Member

31/08/2020

Qing Yang

56 year

Director/Board Member

15/05/2020

Latest Appointments: WuXi AppTec Co., Ltd.

CANbridge Pharmaceuticals Inc. Announces Board and Committee Changes, Effective June 30, 2025	30/06	CI
Dongfeng Motor Group Company Limited Announces Resignation of Zhou Zhiping as Executive Director and President	26/03	CI
WuXi AppTec Co., Ltd. Announces Board Changes	22/01	CI
WuXi AppTec Co., Ltd. Announces Directorate Changes	12/12	CI
Innuovo Technology Co., Ltd. Approves Board Appointments	07/24/07	CI
Huanghe Whirlwind Names Chairman, Vice Chairman	12/24/12	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	07/24/07

More news

Former Officers and Directors: WuXi AppTec Co., Ltd.

Insider

Positions held

SinceUntil

Dai Feng

Director/Board Member	01/12/2018	22/01/2025
Independent Dir/Board Member	01/12/2018	22/01/2025

Shu Hui Chen

Chief Tech/Sci/R&D Officer	01/01/2004	23/03/2016
Corporate Officer/Principal	01/01/2004	10/04/2024

Chi Yao

Investor Relations Contact	-	06/06/2023
Corporate Secretary	23/03/2016	06/06/2023

Jiang Nan Cai

Director/Board Member	01/03/2017	31/05/2023
Independent Dir/Board Member	01/03/2017	31/05/2023

Yan Liu

Director/Board Member	17/03/2017	31/05/2023
Independent Dir/Board Member	17/03/2017	31/05/2023

He Tong Lou

Director/Board Member	01/03/2017	31/05/2023
Independent Dir/Board Member	01/03/2017	31/05/2023

Xiao Tong Zhang

Director/Board Member	01/03/2017	31/05/2023
Independent Dir/Board Member	01/03/2017	31/05/2023

Ning Zhao

Director/Board Member	01/01/2009	16/05/2023
Founder	01/12/2000	16/05/2023
Human Resources Officer	-	23/03/2016
Corporate Officer/Principal	01/01/2004	16/05/2023

Jane Wang

Corporate Officer/Principal

01/03/2010

01/07/2022

Wing Kit Siu

Corporate Secretary

24/03/2020

25/05/2022

Ji Chao Wang

Director/Board Member

11/03/2016

31/08/2020

Wing Yan Yuen

Corporate Secretary

24/03/2020

Yan Wu Tu

Director of Finance/CFO

01/12/2015

01/09/2018

Jin Jin Liang

Corporate Officer/Principal

01/10/2015

01/09/2017

Yan Ling Cao

Director/Board Member

28/02/2017

Bin Li

Director/Board Member

28/02/2017

Kai Gu

Chairman

10/03/2016

Ying Han

Director/Board Member

14/07/2014

Yong Xiang Wang

Corporate Officer/Principal

01/10/2012

01/02/2014

Yi Feng Shi

Compliance Officer	01/08/2011	01/12/2012
General Counsel	01/08/2011	01/12/2012

Ben R. Chen

General Counsel

01/12/2012

Heather D. Malicki

Chief Tech/Sci/R&D Officer

01/01/2012

Wei-Min Chang

Corporate Officer/Principal

23/06/2009

Kwan Hung Tsang

Director of Finance/CFO

01/07/2006

28/02/2009

Hai Mi

Public Communications Contact

01/01/2005

01/01/2009

Bob Zhu

Human Resources Officer

03/07/2008

John Baldwin

Director/Board Member	01/01/2000	-
Founder	01/01/2000	-

Jun Xiao

Corporate Officer/Principal

01/01/2006

Su Han Tang

Corporate Officer/Principal

01/01/2003

Charles Hsu

Chairman

01/01/2002

Xiao Zhong Liu

Director/Board Member	01/01/2001	-
Founder	01/12/2000	-
Corporate Officer/Principal	01/01/2001	-

Tao Lin

Director/Board Member	01/12/2000	-
Founder	01/12/2000	-
Corporate Officer/Principal	01/12/2000	-

Neng Yang Shih

Director/Board Member

20/09/2012

Gersen Gabriel

Corporate Officer/Principal

Zhi Sheng Chen

Director/Board Member	-	-
Chief Executive Officer	-	-

Xiao Feng

Corporate Officer/Principal

Jane Lin

General Counsel

21/04/2011

Chun Sing Li

Corporate Officer/Principal

21/04/2011

Zhongren Wu

Corporate Officer/Principal

21/04/2011

Fang Liu

Corporate Officer/Principal

25/01/2011

Jian Li

Corporate Officer/Principal

25/01/2011

Jing Xu

Corporate Officer/Principal

John Long

Director of Finance/CFO

Joseph Vacca

Corporate Officer/Principal

De Ming Xu

Corporate Officer/Principal

Yi Ning Qi

Corporate Officer/Principal

Qiang Lü

Corporate Officer/Principal

Alexander Fowkes

Corporate Officer/Principal

Eugene Gong

Chief Tech/Sci/R&D Officer

Deepak Hegde

Corporate Officer/Principal

Chungang Li

Chief Tech/Sci/R&D Officer

Linus Lin

Corporate Officer/Principal

Ee Hoon See

Human Resources Officer

Naruhito Masai

Corporate Officer/Principal

Robert Coldreck

Corporate Officer/Principal

Steve Mason

Corporate Officer/Principal

Jin Song Xing

Corporate Officer/Principal

Scott Kramer

Corporate Officer/Principal

Alan W. Moore

Corporate Officer/Principal

Lisa Olson

Corporate Officer/Principal

Teri Tanquist

Corporate Officer/Principal

Wensheng Liao

Corporate Officer/Principal

Xiang Li Liu

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Age distribution of managers

Parity Men Women

Male	32
Female	6

Of which Executive Committee

Male	8
Female	3

Of which Directors

Male	12
Female	3

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

AAA

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.; - CMO and CDMO services (31.9%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.; - clinical research services (7.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.; - other (0.1%). Net sales are distributed geographically as follows: China (25.1%), Asia (4.1%), the United States (53.6%), Europe (16%) and other (1.2%) .

Employees

39,414

Sector

Biotechnology & Medical Research

Calendar

29/07 - Q2 2025 Earnings Release

More about the company